Jump to content

Siguazodan

Edit links
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Rogermx (talk | contribs) at 17:19, 26 December 2017. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Siguazodan
Names
IUPAC name
1-Cyano-2-methyl-3-[4-(4-methyl-6-oxo-4,5-dihydro-1H-pyridazin-3-yl)phenyl]guanidine
Identifiers
3D model (JSmol)
ChemSpider
ECHA InfoCard 100.162.222 Edit this at Wikidata
  • InChI=1S/C14H16N6O/c1-9-7-12(21)19-20-13(9)10-3-5-11(6-4-10)18-14(16-2)17-8-15/h3-6,9H,7H2,1-2H3,(H,19,21)(H2,16,17,18)
    Key: NUHPODZZKHQQET-UHFFFAOYSA-N
  • CC1CC(=O)NN=C1C2=CC=C(C=C2)NC(=NC)NC#N
Properties
C14H16N6O
Molar mass 284.323 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

Siguazodan is a phosphodiesterase inhibitor.[1]

References

  1. ^ Sosroseno, W; Sugiatno, E (2008). "Cyclic-AMP-dependent proliferation of a human osteoblast cell line (HOS cells) induced by hydroxyapatite: Effect of exogenous nitric oxide". Acta bio-medica : Atenei Parmensis. 79 (2): 110–6. PMID 18788505.


Stub icon

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Siguazodan&oldid=817170977"